107 related articles for article (PubMed ID: 11399944)
1. Expression of ETS-1 is correlated with urokinase-type plasminogen activator and poor prognosis in pulmonary adenocarcinoma.
Takanami I; Takeuchi K; Karuke M
Tumour Biol; 2001; 22(4):205-10. PubMed ID: 11399944
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of Ets-1 transcription factor and the urokinase-type plasminogen activator is correlated with the malignant and invasive potential in meningiomas.
Kitange G; Tsunoda K; Anda T; Nakamura S; Yasunaga A; Naito S; Shibata S
Cancer; 2000 Dec; 89(11):2292-300. PubMed ID: 11147600
[TBL] [Abstract][Full Text] [Related]
3. Ets-1 proto-oncogene as a potential predictor for poor prognosis of lung adenocarcinoma.
Yamaguchi E; Nakayama T; Nanashima A; Matsumoto K; Yasutake T; Sekine I; Nagayasu T
Tohoku J Exp Med; 2007 Sep; 213(1):41-50. PubMed ID: 17785952
[TBL] [Abstract][Full Text] [Related]
4. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R
Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654
[TBL] [Abstract][Full Text] [Related]
5. Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas.
Bolon I; Gouyer V; Devouassoux M; Vandenbunder B; Wernert N; Moro D; Brambilla C; Brambilla E
Am J Pathol; 1995 Nov; 147(5):1298-310. PubMed ID: 7485393
[TBL] [Abstract][Full Text] [Related]
6. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.
Davidson B; Reich R; Goldberg I; Gotlieb WH; Kopolovic J; Berner A; Ben-Baruch G; Bryne M; Nesland JM
Clin Cancer Res; 2001 Mar; 7(3):551-7. PubMed ID: 11297247
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the proto-oncogene c-ets 1 and the urokinase plasminogen activator during mouse implantation and placentation.
Grevin D; Chen JH; Raes MB; Stehelin D; Vandenbunder B; Desbiens X
Int J Dev Biol; 1993 Dec; 37(4):519-29. PubMed ID: 8179996
[TBL] [Abstract][Full Text] [Related]
8. Expression of the ets-1 proto-oncogene in human colorectal carcinoma.
Nakayama T; Ito M; Ohtsuru A; Naito S; Sekine I
Mod Pathol; 2001 May; 14(5):415-22. PubMed ID: 11353051
[TBL] [Abstract][Full Text] [Related]
9. c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans.
Wernert N; Raes MB; Lassalle P; Dehouck MP; Gosselin B; Vandenbunder B; Stehelin D
Am J Pathol; 1992 Jan; 140(1):119-27. PubMed ID: 1370594
[TBL] [Abstract][Full Text] [Related]
10. Expression of ets-1 and ets-2 in colonic neoplasms.
Ito Y; Takeda T; Okada M; Matsuura N
Anticancer Res; 2002; 22(3):1581-4. PubMed ID: 12168840
[TBL] [Abstract][Full Text] [Related]
11. Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions.
Bolon I; Brambilla E; Vandenbunder B; Robert C; Lantuejoul S; Brambilla C
Lab Invest; 1996 Jul; 75(1):1-13. PubMed ID: 8683934
[TBL] [Abstract][Full Text] [Related]
12. Expression of the ets-1 proto-oncogene in human pancreatic carcinoma.
Ito T; Nakayama T; Ito M; Naito S; Kanematsu T; Sekine I
Mod Pathol; 1998 Feb; 11(2):209-15. PubMed ID: 9504693
[TBL] [Abstract][Full Text] [Related]
13. Expression of Ets-1 angiogenesis-related protein in gastric cancer.
Tsutsumi S; Kuwano H; Asao T; Nagashima K; Shimura T; Mochiki E
Cancer Lett; 2000 Nov; 160(1):45-50. PubMed ID: 11098083
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical evidence of urokinase-type plasminogen activator in primary and metastatic tumors of pulmonary adenocarcinoma.
Oka T; Ishida T; Nishino T; Sugimachi K
Cancer Res; 1991 Jul; 51(13):3522-5. PubMed ID: 2054790
[TBL] [Abstract][Full Text] [Related]
15. Urokinase and plasminogen activator inhibitor type 1 in pulmonary adenocarcinoma.
Pedersen H; Grøndahl-Hansen J; Francis D; Osterlind K; Hansen HH; Danø K; Brünner N
Cancer Res; 1994 Jan; 54(1):120-3. PubMed ID: 8261432
[TBL] [Abstract][Full Text] [Related]
16. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells.
Iwasaka C; Tanaka K; Abe M; Sato Y
J Cell Physiol; 1996 Dec; 169(3):522-31. PubMed ID: 8952701
[TBL] [Abstract][Full Text] [Related]
17. Ets-1 and VEGF expression correlates with tumor angiogenesis, lymph node metastasis, and patient survival in esophageal squamous cell carcinoma.
Mukherjee T; Kumar A; Mathur M; Chattopadhyay TK; Ralhan R
J Cancer Res Clin Oncol; 2003 Jul; 129(7):430-6. PubMed ID: 12851814
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen Activation System in Rectal Adenocarcinoma.
Razik E; Kobierzycki C; Grzegrzolka J; Podhorska-Okolow M; Drag-Zalesinska M; Zabel M; Dziegiel P
Anticancer Res; 2015 Nov; 35(11):6009-15. PubMed ID: 26504024
[TBL] [Abstract][Full Text] [Related]
19. The Clinical Study of Urokinase-Type Plasminogen Activator and Vascular Endothelial Growth Factor in Gastric Cancer.
Yang XW; Gao F; Chen YJ; Teng FM
Cell Biochem Biophys; 2015 Jul; 72(3):649-52. PubMed ID: 27352182
[TBL] [Abstract][Full Text] [Related]
20. Expression of urokinase plasminogen activator and receptor in conjunction with the ets family and AP-1 complex transcription factors in high grade prostate cancers.
Gavrilov D; Kenzior O; Evans M; Calaluce R; Folk WR
Eur J Cancer; 2001 May; 37(8):1033-40. PubMed ID: 11334730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
